OBV/PTV/r) ± ribavirin (RBV)

DRUG2 trials

Sponsors

Beni-Suef University, Tanta University

Conditions

HCV Infection ( Genotype 4) in CKD PatientsHepatitis C Virus Infection

Phase 1

Ombitasvir /Paritaprevir/Ritonavir Plus Ribavirin on HCV GT4

CompletedNCT04378608

Beni-Suef UniversityHepatitis C Virus Infection

Start: 2017-01-05End: 2017-09-08Updated: 2020-05-12

Phase 2

Treatment of CKD Patients With HCV

Not yet recruitingNCT07770984

Tanta UniversityHCV Infection ( Genotype 4) in CKD Patients

Start: 2026-09-15End: 2027-05-15Target: 50Updated: 2026-08-20

Related Papers

Effectiveness of Ombitasvir with Paritaprevir/Ritonavir plus Ribavirin on the Treatment of Naïve Patients with Chronic Hepatitis C Virus Genotype 4

Iraqi Journal of Pharmaceutical Sciences ( P-ISSN 1683 - 3597 E-ISSN 2521 - 3512)2022-06-12